Clinical Trial Update: Prevalence of Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

View source ↗

Summary

A registry entry describes a study on the prevalence of obesity in metabolic dysfunction-associated steatotic liver disease (MASLD), including lean MASLD, and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: Assiut University | Conditions: Lean MASLD | Status: NOT_YET_RECRUITING